The retraction note, posted last week, comes two years after Spectrum reported on backlash surrounding the paper, which was published in the Journal of Autism and Developmental Disorders in July 2021
doi: 10.1002/edm2.v7.1 11 PerkovicVTuttleKRRossingPMahaffeyKWMannJFEBakrisGet al
Metabolic & Multi-Agonist Research Compounds explored in insulin signalling and metabolic pathways
These inflammatory responses were dose-dependent, with a pronounced immune response in the high-dose groups
Breastfeeding The safety of semaglutide during breastfeeding remains uncertain: Injectable Forms (Ozempic, Wegovy): Limited data suggest that semaglutide may be present in breast milk, although its unclear what impact, if any, this might have on a nursing infant
doi:10.1016/j.cmet.2011.08.014 9